KRTL BioTech

SoftBank’s China strategy wobbles as key bets disappoint

SoftBank’s China strategy wobbles as key bets disappoint

For SoftBank Group Inc, financial technology firm OneConnect's IPO should have been a vindication of an aggressive China investing strategy.